Sichuan Biokin Pharmaceutical (688506.SH) plans to repurchase shares worth 100 million to 200 million yuan.
Bailitianheng (688506.SH) announced that the company plans to repurchase 100 million to 200 million yuan worth of shares, with a repurchase price not exceeding 398 yuan per share. The repurchased shares will be used in the future at an appropriate time to implement an employee shareholding plan or equity incentive.
Sichuan Biokin Pharmaceutical (688506.SH) announced that the company plans to repurchase shares worth 100 million to 200 million yuan, with a repurchase price not exceeding 398 yuan per share. The repurchased shares will be used in the future at an appropriate time for the implementation of employee shareholding plans or equity incentives.
Related Articles
HANXBIO-B (03378) spent approximately HK$517,600 to repurchase 18,700 shares on June 1st.
Meituan conference call: Expected Q2 food delivery user experience will be significantly better than Q1.
CHERY AUTO(09973): The total sales volume of five major brands in May was 231,900 cars, an increase of approximately 20.7% year-on-year.
HANXBIO-B (03378) spent approximately HK$517,600 to repurchase 18,700 shares on June 1st.
Meituan conference call: Expected Q2 food delivery user experience will be significantly better than Q1.
CHERY AUTO(09973): The total sales volume of five major brands in May was 231,900 cars, an increase of approximately 20.7% year-on-year.
